Literature DB >> 30276642

A New N Staging System for Colorectal Cancer in the Era of Extended Lymphadenectomy.

Eiji Shinto1, Jin-Ichi Hida2, Hideyuki Ike3, Hirotoshi Kobayashi4, Yojiro Hashiguchi5, Kazuo Hase6, Hideki Ueno6, Kenichi Sugihara7.   

Abstract

BACKGROUND: Complete mesocolic excision is becoming popular in colon cancer surgery in Western countries, and in the tumor-node-metastasis (TNM) classification of rectal cancer, a part of the lateral pelvic lymph nodes is classified as regional. However, the appropriateness of TNM staging according to the assessment of nodal status exclusively by extended lymphadenectomy remains unclear. PATIENTS AND METHODS: Using a nationwide multicenter database in Japan, we retrospectively analyzed 6866 patients with stage III colorectal cancer (CRC) treated with extended (D3) dissection. First, the best cutoff values for the number of metastatic nodes were explored. Second, the utility of the metastatic status of the main lymph nodes (i.e., at the origin of the feeding artery) and the lateral pelvic lymph nodes ("jN3" category in the Japanese staging system) as N staging criteria was evaluated. The modified N staging system that had the best risk stratification power was determined according to the Akaike information criterion (AIC).
RESULTS: Excellent performance was noted when the number of metastatic nodes was categorized by cutoff values of "3/4" and "6/7." Categorization of nodal metastasis was proven the most clinically efficacious when classified as modified-N1 (N1 and jN3-negative), modified-N2a (N2a and jN3-negative), and modified-N2b (N2b and/or jN3-positive; AIC, 22,810.8), rather than the classification based on the TNM (AIC, 22,849.2) or Japanese staging system (AIC, 22,811.1).
CONCLUSIONS: We structured a modified N staging system according to the number and extent of lymph node metastases. The modified system may be used in stage III cases for precise risk stratification.

Entities:  

Mesh:

Year:  2018        PMID: 30276642     DOI: 10.1245/s10434-018-6786-x

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  5 in total

1.  Comparison of model fit and discriminatory ability of the 8th edition of the tumor-node-metastasis classification and the 9th edition of the Japanese classification to identify stage III colorectal cancer.

Authors:  Kei Kitamura; Dai Shida; Shigeki Sekine; Yuka Ahiko; Yuya Nakamura; Konosuke Moritani; Shunsuke Tsukamoto; Yukihide Kanemitsu
Journal:  Int J Clin Oncol       Date:  2021-06-03       Impact factor: 3.402

2.  Prognostic Impact of the Number of Examined Lymph Nodes in Stage II Colorectal Adenocarcinoma: A Retrospective Study.

Authors:  Purun Lei; Ying Ruan; Jianpei Liu; Qixian Zhang; Xiao Tang; Juekun Wu
Journal:  Gastroenterol Res Pract       Date:  2020-06-24       Impact factor: 2.260

3.  Serum calcium improved systemic inflammation marker for predicting survival outcome in rectal cancer.

Authors:  Zhuokai Zhuang; Xiaolin Wang; Meijin Huang; Yanxin Luo; Huichuan Yu
Journal:  J Gastrointest Oncol       Date:  2021-04

4.  Proposal of a modified subclassification system for stage III colorectal cancer: A multi-institutional retrospective analysis.

Authors:  Eiji Shinto; Hideyuki Ike; Jin-Ichi Hida; Hirotoshi Kobayashi; Yojiro Hashiguchi; Kazuo Hase; Yoji Kishi; Hideki Ueno; Kenichi Sugihara
Journal:  Ann Gastroenterol Surg       Date:  2020-07-23

5.  Allocating colorectal cancer patients to different risk categories by using a five-biomarker mRNA combination in lymph node analysis.

Authors:  Lina Olsson; Marie-Louise Hammarström; Anne Israelsson; Gudrun Lindmark; Sten Hammarström
Journal:  PLoS One       Date:  2020-02-12       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.